INAF is EnoughINAF . D1. No pattern. Speculative entry.
Entry point 940-960. Low risk, only 2.6% risk.
TP1 1100
TP2 1350
SL 935
−224 IDR
−720.99 B IDR
523.60 B IDR
371.73 M
About INDOFARMA TBK
Sector
CEO
Yeli Andriani
Headquarters
Bekasi
Founded
1918
ISIN
ID1000068406
FIGI
BBG000D7RNM5
PT Indofarma Tbk engages in the provision of pharmaceutical and healthcare businesses. It operates through the following segments: Medicine, Medical Devices & Others, Engineering Pharmaceutical, and Strategic Alliances. The Medicine segment includes drug production, marketing, distribution, and sales. The Medical Devices & Others segment refers to products developed by the company in the form of instruments, apparatus, and/or implants; as well as other household healthcare supplies. The Engineering Pharmaceutical segment refers to the Indomach business unit, which manufactures, sells, and maintains machineries for the pharmaceutical industry. The company was founded in 1918 and is headquartered in Bekasi, Indonesia.
INAF Strong Support at 880INAF still has no find any strong support yet. 880 could be the strong support to rebound.
inaf menuju gapinaf menuju gap di bawah 4230 .target jangka menengah nya ada di 5670 - 5910. untuk jangka panjang nya ada di 6500
support minor ada di 3740 dan 3520 sebagai support selanjutnya
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of INAF is 126 IDR — it hasn't changed in the past 24 hours. Watch INDOFARMA TBK stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange INDOFARMA TBK stocks are traded under the ticker INAF.
INAF reached its all-time high on Jan 13, 2021 with the price of 7,350 IDR, and its all-time low was 50 IDR and was reached on Oct 27, 2008. View more price dynamics on INAF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INAF stock is 0.00% volatile and has beta coefficient of 5.32. Track INDOFARMA TBK stock price on the chart and check out the list of the most volatile stocks — is INDOFARMA TBK there?
Today INDOFARMA TBK has the market capitalization of 390.51 B, it has decreased by −7.35% over the last week.
Yes, you can track INDOFARMA TBK financials in yearly and quarterly reports right on TradingView.
INAF net income for the last quarter is −64.54 B IDR, while the quarter before that showed −48.00 B IDR of net income which accounts for −34.48% change. Track more INDOFARMA TBK financial stats to get the full picture.
No, INAF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 1.09 K employees. See our rating of the largest employees — is INDOFARMA TBK on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INDOFARMA TBK EBITDA is −446.46 B IDR, and current EBITDA margin is −92.24%. See more stats in INDOFARMA TBK financial statements.
Like other stocks, INAF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INDOFARMA TBK stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INDOFARMA TBK technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INDOFARMA TBK stock shows the sell signal. See more of INDOFARMA TBK technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.